Applied Intuition Launches Dana, the Agentic Platform for Physical AI
New platform pairs agentic AI with the tooling, data, infrastructure and domain expertise Applied Intuition has built over nearly a decade to speed the safe development of intelligent machines for the physical world. Dana is the first agentic...
Phase II Trial of Cadonilimab(PD-1/CTLA-4) Combination Regimen Launches in the United States for Perioperative Treatment of Gastric Cancer
HONG KONG, July 14, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that it has entered into a collaboration with Memorial Sloan Kettering Cancer Center (MSKCC) to advance a Phase II clinical study evaluating a...
Akeso and INOVIO Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)
Collaboration will evaluate Akeso's cadonilimab in combination with INOVIO's INO-5412 (INO-5401 plus INO-9012) as a potential treatment for glioblastoma (GBM), the most common and aggressive form of brain cancer Novel combination therapy will be...
The AI Alliance releases new AI-powered programming language and industrial AI agent framework, adds new Japanese members, and launches AI Alliance Japan
TOKYO, June 26, 2025 /PRNewswire/ -- Today the AI Alliance, a global non-profit consortium dedicated to open-source AI innovation, announced Dana, a new open-source AI-powered programming language, and the OpenDXA agent framework for industrial AI....